See other companies on Welcome to the Jungle
PatientIQ
Cloud-based patient engagement technology
- 21-100 employees
- Healthcare
- B2B
- Big data
- Analytics
- SaaS
- River North, Chicago, IL
Jump to section
Company mission
To be a single, transparent, and easy-to-use solution that enables users to systemically collect, measure, analyze patient outcomes data to drive medicine forward.
Few candidates hear
back within 2 weeks
23% employee growth in 12 months
Our take
Improving patient outcomes is an increasing priority in the US healthcare system, and studies suggest this comes not from spending more, but spending smarter. PatientIQ is a platform aiming to achieve just this, translating patient outcome data into actionable insights that can improve clinical care.
The healthcare industry has been slow to adopt the use of big data in comparison with sectors such as finance and engineering, but PatientIQ's platform is clearly gaining traction in the market, with over 5,000 healthcare providers and over 1.5 million patients on its platform. In addtion to data collection and analytics, PatientIQ automates clinical workflows and allows for collaborative work with other organizations in its network, further boosting patient outcomes and clincial decision making.
PatientIQ's plaform is designed to accrue value more gradually than its competitors, building on data-sharing and collaborative insights from users rather than providing a one-size-fits-all solution. PatientIQ claims to be the fastest growing network for collaborative clinical research and its growth is evident through the significant funding it has raised. PatientIQ will use this investment to enhance its platform and accelerate its expansion in the global market.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Unlimited time off
- Remote friendly
- Meaningful equity
- Comprehensive benefits
- Social events
- Fast growing
Company values
- Human-Centered
- Continuous Improvement
- Collaboration
- Dependability
Funding (1 round)
May 2022
$20m
SERIES B
Total funding: $20m
Leadership
Matthew Gitelis
(CEO)A qualified MD and former financial analyst who worked at companies such as BMO Capital Markets. They also worked as a researcher at Rush Medical College.